Publications by authors named "D D Chi"

Peripheral nerve injury (PNI)-induced neuropathic pain (NP) is a severe disease with high prevalence in clinics. Gene reprogramming and tissue remodeling in the dorsal root ganglia (DRG) and spinal cord (SC) drive the development and maintenance of neuropathic pain (NP). However, our understanding of the NP-associated spatial molecular processing landscape of SC and the non-synaptic interactions between DRG neurons and SC cells remains limited.

View Article and Find Full Text PDF
Article Synopsis
  • Germline genetic testing (GT) is recommended for ovarian cancer (OC) and some endometrial cancer (EC) patients, but participation is low due to various barriers.
  • A quality improvement study at a medical center tracked 116 newly diagnosed OC/EC patients, achieving high GT rates (91% for OC, 75% for EC) and rapid result availability.
  • Identified barriers include missed recommendations, patient overwhelm, financial/privacy concerns, and language issues; the study suggests enhancing GT encouragement throughout treatment and offering multilingual digital consent options.
View Article and Find Full Text PDF

Background: The COVID-19 pandemic has led to increased depressive symptoms and diminished sleep quality among nurses. This study explores the relationships among social support, sleep quality, and depressive symptoms among Chinese nurses during the COVID-19 outbreak, with a focus on the mediating role of sleep quality.

Methods: A cross-sectional study involving 2140 nurses was conducted from August to September 2022.

View Article and Find Full Text PDF

Objectives: Tinnitus is a common otologic complaint which can range from bothersome to debilitating. Imaging is frequently utilized to rule out tumors, fractures, and other causes but can also cause significant medical and economic burden for patients. Furthermore, the pediatric population may require sedation for imaging.

View Article and Find Full Text PDF

Objective: We sought to describe the association between genomic instability score (GIS) and progression-free survival (PFS) and overall survival (OS) in patients with newly diagnosed, non-BRCA1/2 ovarian cancer.

Methods: Homologous recombinant deficiency (HRD) status was based on a cutoff of ≥42 GIS; patients <42 were categorized with homologous recombination proficiency (HRP). We collected type and duration of maintenance therapy, among other variables, and built a multivariate model with landmark analysis at 6 months from baseline and applied it for time-dependent variables.

View Article and Find Full Text PDF